A Multicenter, Randomized, Double-blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder
Phase of Trial: Phase III
Latest Information Update: 16 Nov 2017
At a glance
- Drugs Brexpiprazole (Primary)
- Indications Bipolar I disorders; Manic episodes
- Focus Therapeutic Use
- Sponsors Otsuka Pharmaceutical Development & Commercialization
- 08 Nov 2017 Planned End Date changed from 1 Nov 2018 to 1 Jan 2019.
- 08 Nov 2017 Planned primary completion date changed from 1 Nov 2018 to 1 Jan 2019.
- 11 Oct 2017 According to an Otsuka Pharmaceuticals media release, status changed from not yet recruiting to recruiting.